ClinicalTrials.gg
RecruitingNCT07629297Updated Sep 23, 2026

A Korean Point Prevalence Study of Acute Rehabilitation for Kids in the PICU (PARK-PICU)

An observational study in Pediatric Intensive Care Units, sponsored by Samsung Medical Center. Recruiting at 13 sites in South Korea. Open to participants aged 0 Days to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Samsung Medical Center · Observational

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
396
Ages
0 Days to 18 Years
Sex
All
01

Study summary

This study investigates the prevalence of acute rehabilitation practices among children in pediatric intensive care units (PICUs).

Read the detailed description

This is a prospective observational study conducted across 13 hospitals. Data will be collected at three predefined time points to assess the prevalence of acute rehabilitation practices among children in pediatric intensive care units.

02

Conditions studied

  • Pediatric Intensive Care Units

Browse trials for

Keywords

  • Pediatric Intensive Care Units
  • Acute Rehabilitation
  • Rehabilitation Prevalence
  • Child
  • Critical Illness
  • Intensive Care Unit Acquired Weakness
03

In context

Critical Illness

1,780 studies on the registry are indexed under Critical Illness; 442 are open to participants now.

This study's planned enrollment of 396 is above the median of 140 across 814 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Samsung Medical Center is the lead sponsor of 1,011 studies on the registry; 152 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population includes critically ill children and adolescents aged 18 years or younger who are admitted to pediatric intensive care units (PICUs) at participating hospitals in South Korea. Patients who have been hospitalized in the PICU for at least 72 hours as of 9:00 AM on predefined study dates will be included. All eligible patients at each study time point will be included to reflect real-world clinical practice in pediatric critical care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents aged 18 years or younger who have been admitted to the pediatric intensive care unit (PICU) for at least 72 hours as of 9:00 AM on the predefined study date at participating hospitals.

Exclusion criteria

Exclusion Criteria:

  • No exclusion criteria. All eligible patients meeting the inclusion criteria will be included to comprehensively assess the real-world prevalence of acute rehabilitation practices and associated barriers in pediatric intensive care units.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
396 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children in Pediatric Intensive Care Units

    Children admitted to pediatric intensive care units (PICUs) who are assessed for the prevalence of acute rehabilitation practices during critical care.

    Other: Acute Rehabilitation (Observed Practice)

Interventions

  • OtherAcute Rehabilitation (Observed Practice)

    This study does not assign any interventions. It observes routine clinical practices of acute rehabilitation provided to children in pediatric intensive care units as part of standard care.

06

What researchers measure

Primary outcomes

  1. Proportion of Participants Who Received Acute Rehabilitation

    Prevalence is defined as the proportion of eligible children in the pediatric intensive care unit who received at least one session of physical therapy or occupational therapy within the 24 hours preceding each study assessment point.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

Secondary outcomes

  1. Number of Acute Rehabilitation Sessions per Participant

    The number of physical therapy or occupational therapy sessions delivered to eligible children within the 24 hours preceding each assessment point.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

  2. Number of Participants by Type of Rehabilitation Intervention

    The types of rehabilitation interventions delivered within the 24 hours preceding each assessment point, including passive exercise, active exercise, positioning, mobility training, and occupational therapy interventions.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

  3. Proportion of sessions Involving Assistive Devices

    The proportion of rehabilitation sessions involving assistive devices or equipment during the 24 hours preceding each assessment point.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

  4. Number of Sessions by Delivery Method

    The types of rehabilitation delivery methods used within the 24 hours preceding each assessment point, including bedside therapy, in-room mobilization, and therapist-assisted mobility interventions.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

  5. Odds Ratios for Factors Associated With Absence of Acute Rehabilitation

    Multivariable logistic regression analysis will be performed to evaluate clinical and organizational factors associated with the absence of acute rehabilitation delivery among eligible children in the pediatric intensive care unit. Predictor variables will include patient demographics, severity of illness, sedation status, mechanical ventilation, restraint use, ICU structure, rehabilitation protocols, and staffing resources.

    Time frame: At three seasonal point-prevalence assessments conducted approximately 6 months apart over an 18-month period

07

Study locations

13 of 13 sites recruiting
08

References and documents

Publications

  • Kudchadkar SR, Nelliot A, Awojoodu R, Vaidya D, Traube C, Walker T, Needham DM; Prevalence of Acute Rehabilitation for Kids in the PICU (PARK-PICU) Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Physical Rehabilitation in Critically Ill Children: A Multicenter Point Prevalence Study in the United States. Crit Care Med. 2020 May;48(5):634-644. doi: 10.1097/CCM.0000000000004291. PubMed 32168030 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2027, 12 months after the start.

Of 439 non-industry observational studies under Critical Illness, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 12 months is below that.

Counting every sponsor, half of 442 studies reached it within 23 months; a quarter within 12 and three quarters within 46.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
May 13, 2026
First posted
Jun 5, 2026
StartActual
May 28, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07629297
Responsible party
Jeong Yi Kwon (professor, Samsung Medical Center) — Principal investigator
First posted
Jun 5, 2026
Start date
May 28, 2026
Primary completion
May 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 23, 2026

Study contacts

yumi choe
Contact
yumi.choe@sbri.co.kr
82-10-3173-2671

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion